The effectiveness of cognitive-behavioral therapy on cardiovascular disease risk factors

The effectiveness of the cognitive-behavioral treatment-based model of Panic Attack Treatment in Comorbid Heart Diseases (PATCHD) on the risk factors of cardiovascular disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220521054950N2

Enrollment

Registered

2024-10-02

Start date

2024-08-22

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Panic disorder. Condition 2: cardiovascular disease. Panic disorder [episodic paroxysmal anxiety] without agoraphobia Cardiovascular disorders originating in the perinatal period

Interventions

Intervention 1: Intervention group: 1-2 session: evaluation and case formulation

Education about heart disease, risk factors and anxiety. 3-4 session: improving coping skills

Reducing behavioral and situational avoidance. 5-6 session: Visceral exposures - starting a supervised exercise program

Mindfulness. 7-8 session: Cognitive Restructuring - Identifying Central Thoughts and Beliefs That Influence Panic Symptoms. Intervention 2: Control group: This group is placed on the waiting list.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Having symptoms of panic disorder and cardiovascular diseases at the same time being at least 18 years old Not undergoing psychiatric (drug) and psychological treatments at the same time, or completing previous psychological treatments up to 6 months before entering the study Not suffering from severe mental disorders

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: One day before the intervention and one day after the intervention. Method of measurement: Mercury sphygmomanometer.;Diabetes. Timepoint: One day before the intervention and one day after the intervention. Method of measurement: Venous blood sample.;Blood lipid profile. Timepoint: One day before the intervention and one day after the intervention. Method of measurement: Venous blood sample.;Inflammation. Timepoint: One day before the intervention and one day after the intervention. Method of measurement: Venous blood sample.;Anxiety. Timepoint: One day before the intervention and one day after the intervention. Method of measurement: Beck's 21-question anxiety questionnaire.;Depression. Timepoint: One day before the intervention and one day after the intervention. Method of measurement: Patient health questionnaire.	—

Measure

Time frame

Blood pressure. Timepoint: One day before the intervention and one day after the intervention. Method of measurement: Mercury sphygmomanometer.;Diabetes. Timepoint: One day before the intervention and one day after the intervention. Method of measurement: Venous blood sample.;Blood lipid profile. Timepoint: One day before the intervention and one day after the intervention. Method of measurement: Venous blood sample.;Inflammation. Timepoint: One day before the intervention and one day after the intervention. Method of measurement: Venous blood sample.;Anxiety. Timepoint: One day before the intervention and one day after the intervention. Method of measurement: Beck's 21-question anxiety questionnaire.;Depression. Timepoint: One day before the intervention and one day after the intervention. Method of measurement: Patient health questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Mohebati

Mashhad University of Medical Sciences

mouhebatim@mums.ac.ir+98 51 3858 3854

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026